- Report
- June 2023
- 149 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- May 2024
- 216 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- October 2023
- 150 Pages
Global
From €4654EUR$4,850USD£4,024GBP
- Report
- April 2024
- 180 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 180 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 177 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 120 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- January 2024
- 69 Pages
Global
From €3982EUR$4,150USD£3,443GBP
- Report
- February 2024
- 30 Pages
Global
From €2639EUR$2,750USD£2,282GBP
- Report
- February 2024
- 30 Pages
Global
€3406EUR$3,550USD£2,945GBP
- Report
- February 2024
- 30 Pages
Global
€3406EUR$3,550USD£2,945GBP
- Report
- February 2024
- 30 Pages
Global
€3406EUR$3,550USD£2,945GBP
- Report
- February 2024
- 30 Pages
Global
€3406EUR$3,550USD£2,945GBP
- Report
- February 2024
- 30 Pages
Global
€3406EUR$3,550USD£2,945GBP
- Report
- January 2024
- 99 Pages
Global
From €7628EUR$7,950USD£6,596GBP
The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share.
The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market.
Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more